Patent details

EP1435991 Title: USE OF APLIDINE FOR THE TREATMENT OF PANCREATIC CANCER

Basic Information

Publication number:
EP1435991
PCT Application Number:
PCT/GB/2002/004816
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027701069
PCT Publication Number:
WO/2003/033013
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF APLIDINE FOR THE TREATMENT OF PANCREATIC CANCER
French Title of Invention:
UTILISATION D'APLIDINE POUR LE TRAITEMENT DU CANCER DU PANCREAS
German Title of Invention:
VERWENDUNG VON APLIDINE IN DER BEHANDLUNG VON PANKREASKREBS
SPC Number:

Dates

Filing date:
21/10/2002
Grant date:
15/10/2008
EP Publication Date:
15/10/2008
PCT Publication Date:
24/04/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/07/2004
EP B1 Publication Date:
15/10/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/10/2008
Expiration date:
21/10/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/10/2002
 
 

Name:
PHARMA MAR S.A.
Address:
Calle de la Calera 3, Poligono Industrial de Tres Cantos, 28760 Tres Cantos, Madrid, Spain (ES)

Inventor

1

Name:
HENRIQUEZ R., NeuroPharma S.A.U.
Address:
Spain (ES)

2

Name:
MANGUES R., I. Ric. del H. - Santa Cruz/Pablo
Address:
Spain (ES)

3

Name:
JIMENO J.,Pharma Mar,S.A.U.,Polig.Industr.La Mina
Address:
Spain (ES)

Priority

1

Priority Number:
348412 P
Priority Date:
19/10/2001
Priority Country:
United States (US)

2

Priority Number:
0208624
Priority Date:
15/04/2002
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 38/15;
Filing date Document type Number of pages